VUMC expresses appreciation to NIH director Francis Collins on his retirement 

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Gene discoveries give new hope to people who stutter

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.

‘Multi-omics’ reveals treatment option for breast cancer subtype